| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KLAC | Common Stock | Sale | -$4.6M | -12.1K | -7.07% | $380.31 | 159K | May 2, 2023 | Direct | F1, F2, F3 |
| transaction | KLAC | Common Stock | Sale | -$305K | -801 | -0.5% | $381.34 | 158K | May 2, 2023 | Direct | F1, F3, F4 |
| transaction | KLAC | Common Stock | Sale | -$421K | -1.1K | -0.69% | $382.57 | 157K | May 2, 2023 | Direct | F1, F3, F5 |
| transaction | KLAC | Common Stock | Sale | -$808K | -2.1K | -1.34% | $384.79 | 155K | May 2, 2023 | Direct | F1, F3, F6 |
| transaction | KLAC | Common Stock | Sale | -$540K | -1.4K | -0.9% | $385.82 | 154K | May 2, 2023 | Direct | F1, F3, F7 |
| holding | KLAC | Common Stock | 9.18K | May 2, 2023 | By Trust | F8 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on February 7, 2023, as amended on February 15, 2023. |
| F2 | Represents the weighted average sales price for the shares. The sales prices ranged from $380.00 to $380.95. The Reporting Person will provide upon request full information regarding the number of shares sold at each separate price. |
| F3 | The number of shares of KLA common stock includes 107,694 shares issuable upon vesting of restricted stock units ("RSUs"). |
| F4 | Represents the weighted average sales price for the shares. The sales prices ranged from $381.00 to $381.92. The Reporting Person will provide upon request full information regarding the number of shares sold at each separate price. |
| F5 | Represents the weighted average sales price for the shares. The sales prices ranged from $382.18 to $382.84. The Reporting Person will provide upon request full information regarding the number of shares sold at each separate price. |
| F6 | Represents the weighted average sales price for the shares. The sales prices ranged from $384.27 to $385.26. The Reporting Person will provide upon request full information regarding the number of shares sold at each separate price. |
| F7 | Represents the weighted average sales price for the shares. The sales prices ranged from $385.28 to $386.11. The Reporting Person will provide upon request full information regarding the number of shares sold at each separate price. |
| F8 | Shares held under the Wallace Living Trust u/a/d 03/27/01, as amended, a trust of which the Reporting Person is a trustee and beneficiary. |